N nitroso n methyl 4 aminobutyric acid | Radio Compass News | PharmaCompass.com

Market Place

Sourcing support

Sourcing Support

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

All News N-Nitroso-N-Methyl-4-Aminobutyric Acid

Teva recall: Tainted blood pressure drugs continue to show up in U.S. supply

14 Jun 2019 //

FIERCE PHARMA

Vivimed Life Sciences Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg, 50 mg and 100 mg Tablets, USP

04 May 2019 //

FDA

Over 100 lots of losartan tablets recalled after NMBA detected

30 Apr 2019 //

IN-PHARMATECHNOLOGIST

EMA Urges Pioglitazone Manufacturers to Check for Nitrosamine Impurities

26 Apr 2019 //

RAPS

Legacy Pharmaceutical Packaging, Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg

25 Apr 2019 //

FDA

To Prevent Losartan Shortages, FDA Allows Higher Impurity Levels

22 Mar 2019 //

RAPS

FDA updates on recalls of valsartan, losartan and irbesartan

20 Mar 2019 //

FDA

Legacy Pharmaceutical Packaging Issues Recall of Losartan Potassium Tablets

19 Mar 2019 //

FDA

Camber Pharmaceuticals Voluntarily Recalls Losartan Potassium Tablets

01 Mar 2019 //

FDA

Update on the EDQM review of CEP applications for sartan substances (4 Feb 2019)

04 Feb 2019 //

EDQM